Activity of oral β-lactam antimicrobial agents versus respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the era of antibiotic resistance

Otolaryngology - Head and Neck Surgery

Volumn 127, Issue 6 SUPPL., 2002, Pages

  Doern, Gary V ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFACLOR; CEFDINIR; CEFIXIME; CEFPODOXIME PROXETIL; CEFPROZIL; CEFTIBUTEN; CEFUROXIME AXETIL; LORACARBEF; PENICILLIN BINDING PROTEIN; PENICILLIN G; ANTIINFECTIVE AGENT; BETA LACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; DRUG EFFICACY; DRUG RESISTANCE; DRUG SENSITIVITY; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; OUTPATIENT; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; MICROBIOLOGICAL EXAMINATION; ORAL DRUG ADMINISTRATION; REVIEW;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMS; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; STREPTOCOCCUS PNEUMONIAE;

EID: 0038370179     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhn.2002.130029     Document Type: Article

References (20)

1. Doern GV, Brueggemann AB, Pierce G, et al. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother 1997;41:292-7.
2. Barry AL, Pfaller MA, Fuchs PC, et al. In vitro activities of 12 orally administered antimicrobials agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993. Antimicrob Agents Chemother 1994;38:2419-25.
3. Rittenhouse SF, Miller LA, Kaplan RL, et al. A survey of β-lactamase-producing Haemophilus influenzae. An evaluation of 5750 isolates. Diag Microbiol Infect Dis 1995;21:223-5.
4. Richter SS, Brueggemann AB, Huynh HK, et al. A 1997-1998 national surveillance study: Moraxella catarrhalis and Haemophilus influenzae antimicrobials resistance in 34 US institutions. Int J Antimicrob Agents 1999;13:99-107.
5. Richter S, Winokur PL, Brueggemann AB, et al. Molecular characterization of the β-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998. Antimicrob Agents Chemother 2000;44: 444-6.
6. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; twelfth informational supplement (M100-S12). Wayne (PA): National Committee for Clinical Laboratory Standards; 2002.
7. Thornsberry C, Brown SD, Yee YC, et al. Increasing penicillin resistance in Streptococcus pneumoniae in the United States. Suppl Infect Med 1993;93:15-24.
8. Spika JS, Facklam RR, Plikaytis BD, et al, and the Pneumococcal Surveillance Working Group. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J Infect Dis 1991;163:1273-8.
9. Jorgensen JH, Doern GV, Maher LA, et al. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 1990;34:2075-80.
10. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990;3:171-96.
11. Grebe T, Hakenbeck R. Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of β-lactam antibiotics. Antimicrob Agents Chemother 1996;40:829-34.
12. Brueggemann AB, Pfaller MA, Doern GV. Use of penicillin MICs to predict the activity of other β-lactam antimicrobials agents against Streptococcus pneumoniae. J Clin Microbiol 2001;39:367-9.
13. Doern GV, Heilmann KP, Huynh HK, et al. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother 2001;45:1721-9.
14. Markiewicz A, Tomasz A. Variation in penicillin-binding protein patterns of penicillin-resistant clinical isolates of pneumococci. J Clin Microbiol 1989;27:405-10.
15. Feikin DR, Schuchat A, Koczak M, et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance 1995-1997. Am J Public Health 2000;90: 223-9.
16. Turett GS, Blum S, Fazel B, et al. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence. Clin Infect Dis 1999;29: 321-7.
17. Heffelfinger JD, Dowell SF, Jorgensen JH, et al. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med 2000;150:1399-408.
18. Mandell LH. Relationship of penicillin resistance to mortality in penumococcal pneumonia. Curr Infect Dis Rep 2001;3:9-12.
19. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998;26:1-12.
20. Cars O. Efficacy of beta-lactam antibiotics: integration of pharmacokinetics and pharmacodynamics. Diagn Microbiol Infect Dis 1997;27:29-33.